COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of RV6153

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02517359
Recruitment Status : Terminated (Preset pharmacokinetic stopping criteria met at lower doses than expected.)
First Posted : August 7, 2015
Last Update Posted : March 4, 2016
Information provided by (Responsible Party):
Respivert Ltd

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : February 2016
Actual Study Completion Date : February 2016